Dr. Reddy's Laboratories Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Dr. Reddy's Laboratories Ltd. from all sources in a single place.

Load latest

Dr. Reddy's Laboratories Ltd.

10 Jan 2025

1199.80

-0.03%

Can Dr Reddy's shrug off Revlimid's patent expiry?

livemint

DRL also faces headwinds because of increasing competitive intensity in the generic market and exchange rate volatility.

Dr. Reddy's Laboratories Ltd. is trading above its 30 day SMA of 1164.2

Dr. Reddy's Laboratories Ltd.

08 Jan 2025

1199.80

-0.03%

Company Update

DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Earnings Call notification for Q3 FY2025

pdf

Dr. Reddy's Laboratories Ltd.

08 Jan 2025

1199.80

-0.03%

Dr Reddy's share price jumps 4% on Nuvama's upgrade to buy; brokerage sees potential despite risks from Revlimid expiry

livemint

Dr Reddy's share price rose nearly 4% after Nuvama Institutional Equities upgraded its rating to 'Buy' with a target of 1,553, highlighting proactive strategies to mitigate the impact of Revlimid's patent expiration in 2026, despite a 9.35% drop in net profit for September 2024.

Dr. Reddy's Laboratories Ltd. is trading below its 50 day SMA of 1202.6

Dr. Reddy's pops 4% after Nuvama upgrades to 'Buy'; arm sells US mfg unit

Business Standard | 08 Jan 2025 1 more

Dr. Reddy's Laboratories Ltd.

08 Jan 2025

1199.80

-0.03%

Markets fall on global cues; US jobs data dampens rate cut hopes

Business Line

While healthcare and energy stocks, such as Dr. Reddy's Laboratories and ONGC, showed resilience, companies like Trent faced notable losses.

Dr. Reddy's Laboratories Ltd. is trading below its 50 day SMA of 1202.6

Dr. Reddy's Laboratories Ltd.

07 Jan 2025

1199.80

-0.03%

Company Update

DR.REDDY'S LABORATORIES LTD. - 500124 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure …

BSE India

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

pdf

Dr. Reddy's Laboratories Ltd.

07 Jan 2025

1199.80

-0.03%

Dr Reddy Share Price Live blog for 07 Jan 2025

livemint

Dr Reddy Share Price Today Live Updates : Dr Reddy stock price went down today, 07 Jan 2025, by -0.16 %. The stock closed at 1352.75 per share. The stock is currently trading at 1350.65 per share. Investors should monitor Dr Reddy stock price closely in the coming days and weeks to see how it reacts to the news.

Dr. Reddy's Laboratories Ltd. is trading below its 50 day SMA of 1202.6

Dr. Reddy's Laboratories Ltd.

03 Jan 2025

1199.80

-0.03%

Company Update

DR.REDDY'S LABORATORIES LTD. - 500124 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018

pdf

Dr. Reddy's Laboratories Ltd.

01 Jan 2025

1199.80

-0.03%

Dr Reddy Share Price Live blog for 01 Jan 2025

livemint

Dr Reddy Share Price Today Live Updates : Dr Reddy stock price went up today, 01 Jan 2025, by 0.78 %. The stock closed at 1377.55 per share. The stock is currently trading at 1388.25 per share. Investors should monitor Dr Reddy stock price closely in the coming days and weeks to see how it reacts to the news.

Dr. Reddy's Laborato.. has an average target of 1347.12 from 11 brokers.

Dr. Reddy's Laboratories Ltd.

31 Dec 2024

1199.80

-0.03%

Dr Reddy Share Price Live blog for 31 Dec 2024

livemint

Dr Reddy Share Price Today Live Updates : Dr Reddy stock price went down today, 31 Dec 2024, by -1.07 %. The stock closed at 1389.35 per share. The stock is currently trading at 1374.45 per share. Investors should monitor Dr Reddy stock price closely in the coming days and weeks to see how it reacts to the news.